A Corewell Health doctor who worked for over a decade to develop groundbreaking technology died suddenly, just days before he was set to lead the launch at a Michigan hospital.
/PRNewswire/ Cortex announced today the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in late October 2023. The international,.
Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow® (EGF®) Mapping for use in Atrial Fibrillation Ablation streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.